Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial
Edward Clarke;
(2021)
Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Lancet Infectious Diseases.
ISSN 1473-3099
DOI: 10.1016/S1473-3099(20)30735-0.
-
picture_as_pdf - Phase 3 Pneumosil Lancet ID.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads